普萘洛尔治疗婴幼儿浅表型血管瘤207例疗效观察

Efficacy of propranolol hydrochloride in the treatment of 207 cases of infantile superficial hemangioma

目的观察口服普萘洛尔治疗婴幼儿浅表型血管瘤的临床效果。方法选择2012年9月至2019年9月就诊的婴幼儿浅表型血管瘤患儿207例,均口服普萘洛尔治疗。服药后定期复诊,根据具体病情调整用药剂量,观察血管瘤生长情况。结果本组207例患儿平均用药时间为(5.47±1.93)个月,187例在服药1周后瘤体颜色开始变淡、萎缩变软、消退,6个月后,大部分血管瘤瘤体缩小明显,有效率为90.4%。结论口服普萘洛尔对婴幼儿浅表型血管瘤的疗效确切。

Objective To observe the efficacy of oral propranolol hydrochloride in the treatment of infantile superficial hemangioma. Methods A total of 207 infants with superficial hemangioma from September 2012 to 2019 were selected. Oral propranolol hydrochloride was given. Regular follow-up was performed after taking propranolol hydrochloride. The dose was adjusted according to the specific condition and the growth of hemangioma was observed. Results The average treatment time of 207 children in this group was(5.47±1.93) months, 187 cases(90.33%) of superficial hemangioma began to atrophy and fade at 1 week after taking propranolol hydrochloride. After 6 months of treatment, the majority of hemangiomas were significantly reduced. Conclusion The efficacy of oral propranolol hydrochloride in the treatment of infantile superficial hemangioma is accurate.